BBH VanEck Biotech ETF
MVIS US Listed Biotech 25 NR USD

NAV as of 13-May-2022

143.2400

4 Week: 134.84 - 161.97

52 Week: 134.84 - 220.75

Latest Closing Price

143.14

Premium / Discount

-0.08

Expense Ratio

0.35%

Investment Objective

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Main Fund Characteristics

Fund Manager:
VanEck
Asset Under Management:
429,319,629
Launch Date:
19/12/2011
Asset Class:
Equity
Replication Method:
Physical-Full
Number of Holdings:
26
Trading Currency:
USD
Style:
Large Blend
Region/Sector/Strategy:
N.A / Healthcare / N.A
Exchange:
NASDAQ

Performance

Period Performance Returns(%) Volatility(%) Risk Adjusted Performance
YTD-24.401.95-12.49
1 Day3.000.000.00
1 Week0.397.850.05
1 Month-13.9710.86-1.29
3 Months-11.4915.80-0.73
6 Months-24.6820.54-1.20
1 Year-17.6025.64-0.69
2 Years-8.0435.05-0.23
3 Years22.7044.730.51
5 Years20.6053.170.39
10 Years206.1875.532.73

Price History

-

Annual Performance Return

2012201320142015201620172018201920202021
Price (%) 47.222465.494530.354710.2039-15.031516.6311-10.211425.754222.026811.7653
Nav (%) 0.00000.00000.00000.00000.00000.00000.00000.00000.00000.0000
Rank 2.00004.000031.000033.000073.000078.000085.000038.000051.000044.0000

Dividend Frequency

Lastest Dividend

Ex Date Payment Date Dividend Payout per unit
19/12/202126/12/20210.3972
25/12/201929/12/20190.4724
22/12/201929/12/20190.4724
17/12/201721/12/20170.6830
22/12/201329/12/20130.0030
23/12/201230/12/20120.0179

Portfolio Data

Total Number of Holdings: 26

Number of Bond Holdings: 0

Number of Equity Holdings: 25

Total Market Value: 429,319,629

Portfolio Composition

Top 10 Holdings

% Portfolio Weight Shares Owned Shares Changed Market Value
1Amgen Inc13.7413284,899067,156,392

Country Exposure

Regional Exposure

America

Greater Europe

Greater Asia

Market Classification

Market Capitalization

Size% of portfolio
Giant0.00
Large63.86
Medium31.29
Small4.73
Micro0.00

Equity Style Box Breakdown

000Large
000Mid
000Small
ValueBlendGrowth

Value Measures

Price/Prospective Earnings*

12.3947

Price/Book*

3.3851

Price/Sales*

2.0731

Price/Cash Flow*

10.6170

Dividend Yield*

1.0009

Growth Measures

Long-Term Earnings

11.6263

Historical Earnings

27.0916

Sales Growth

24.8796

Cash-Flow Growth

19.7321

Book-Value Growth

21.8139

*Forward-looking based on historical data.

Equity Sector

Number of Bond Holdings

0

Bond Statitics

DetailValue
Average Effective Duration0
Average Effective Maturity (Years)*0
Average Credit Quality0
Average Weighted Coupon*0
Average Weighted Price*0

Bond Style Box Breakdown

000HighQuality
000Med
000Low
LtdModExt
Interest-Rate Sensitivity

Credit Quality

Type% Bonds
N.A

Bond Sector

Type
% Bonds

Bond Maturity

% Bonds
N.A

Data Source: Morningstar

© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:

(1) include the proprietary information of Morningstar and Morningstar’s third party licensors;
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.

Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.

For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.